Emmaus Life Sciences, Inc.
EMMA
$0.0115
-$0.0024-17.27%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.99M | 16.55M | 16.65M | 20.43M | 19.97M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.99M | 16.55M | 16.65M | 20.43M | 19.97M |
| Cost of Revenue | 1.08M | 1.17M | 1.20M | 1.08M | 903.00K |
| Gross Profit | 12.92M | 15.38M | 15.45M | 19.35M | 19.07M |
| SG&A Expenses | 13.49M | 14.87M | 16.69M | 18.64M | 18.89M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.08M | 16.69M | 18.55M | 20.41M | 20.75M |
| Operating Income | -1.09M | -134.00K | -1.89M | 18.00K | -779.00K |
| Income Before Tax | -3.97M | -4.40M | -6.42M | -3.59M | -5.31M |
| Income Tax Expenses | -581.00K | 40.00K | 29.00K | -89.00K | -50.00K |
| Earnings from Continuing Operations | -3.39 | -4.44 | -6.45 | -3.50 | -5.26 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.39M | -4.44M | -6.45M | -3.50M | -5.26M |
| EBIT | -1.09M | -134.00K | -1.89M | 18.00K | -779.00K |
| EBITDA | -1.07M | -113.00K | -1.87M | 41.00K | -753.00K |
| EPS Basic | -0.05 | -0.07 | -0.10 | -0.05 | -0.08 |
| Normalized Basic EPS | -0.04 | -0.04 | -0.07 | -0.04 | -0.05 |
| EPS Diluted | -0.08 | -0.09 | -0.13 | -0.08 | -0.09 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.08 | -0.05 | -0.05 |
| Average Basic Shares Outstanding | 255.46M | 254.95M | 252.93M | 244.24M | 234.02M |
| Average Diluted Shares Outstanding | 354.32M | 353.81M | 351.79M | 343.10M | 318.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |